AU2014900627A0 - Modulation of diseases of the central nervous system and related disorders - Google Patents

Modulation of diseases of the central nervous system and related disorders

Info

Publication number
AU2014900627A0
AU2014900627A0 AU2014900627A AU2014900627A AU2014900627A0 AU 2014900627 A0 AU2014900627 A0 AU 2014900627A0 AU 2014900627 A AU2014900627 A AU 2014900627A AU 2014900627 A AU2014900627 A AU 2014900627A AU 2014900627 A0 AU2014900627 A0 AU 2014900627A0
Authority
AU
Australia
Prior art keywords
diseases
modulation
nervous system
central nervous
related disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014900627A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deakin University
Original Assignee
Deakin University
Filing date
Publication date
Application filed by Deakin University filed Critical Deakin University
Publication of AU2014900627A0 publication Critical patent/AU2014900627A0/en
Priority to PCT/AU2015/050078 priority Critical patent/WO2015127512A1/en
Priority to EP15755865.1A priority patent/EP3110414B1/en
Priority to AU2015222697A priority patent/AU2015222697B2/en
Priority to US15/121,652 priority patent/US10568862B2/en
Priority to NZ723668A priority patent/NZ723668B2/en
Priority to CA2940573A priority patent/CA2940573C/en
Abandoned legal-status Critical Current

Links

AU2014900627A 2014-02-26 2014-02-26 Modulation of diseases of the central nervous system and related disorders Abandoned AU2014900627A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/AU2015/050078 WO2015127512A1 (en) 2014-02-26 2015-02-26 Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders
EP15755865.1A EP3110414B1 (en) 2014-02-26 2015-02-26 Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders
AU2015222697A AU2015222697B2 (en) 2014-02-26 2015-02-26 Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders
US15/121,652 US10568862B2 (en) 2014-02-26 2015-02-26 Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders
NZ723668A NZ723668B2 (en) 2014-02-26 2015-02-26 Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders
CA2940573A CA2940573C (en) 2014-02-26 2015-02-26 Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders

Publications (1)

Publication Number Publication Date
AU2014900627A0 true AU2014900627A0 (en) 2014-03-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP3448389A4 (en) Quinazoline and indole compounds to treat medical disorders
EP3169260A4 (en) Methods and systems for treating diabetes and related diseases and disorders
EP3212191A4 (en) Treatment for depression and depressive disorders
EP3185876A4 (en) Compositions and methods for treatment of neurological disorders
EP3526319A4 (en) Compositions and methods for treating diseases and disorders of the central nervous system
EP3183005A4 (en) Methods and compositions for the treatment of metabolic disorders
EP3212137A4 (en) Systems and methods for the treatment of eye conditions
EP3110974A4 (en) Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
EP3191108A4 (en) Neural microphysiological systems and methods of using the same
EP3209320A4 (en) Methods of using interleukin-10 for treating diseases and disorders
EP3104776A4 (en) Diagnosis and treatment of respiratory disorders
EP3195291A4 (en) Brain stimulation system and uses thereof
EP3197440A4 (en) Treatment of anxiety disorders and autism spectrum disorders
EP3137481A4 (en) Membrane-adherent self-assembled systems for treatment of ocular disorders
EP3507371A4 (en) Methods and compositions for treating diseases and disorders of the nervous system
EP3145543A4 (en) Treatment of eosinophil or mast cell related disorders
EP3731859A4 (en) Methods of treating disorders associated with castor
EP3258930A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
EP3107546A4 (en) Therapeutic methods employing noribogaine and related compounds
EP3052137A4 (en) Methods for the identification, assessment, prevention, and treatment of neurological disorders and diseases using fndc5
EP3347011A4 (en) Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
EP3206708A4 (en) Methods and compositions for the treatment of radiation-related disorders
EP3107534A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP3347012A4 (en) Muscarinic combinations and their use for combating hypocholinergic disorders of the central nervous system
EP3110414A4 (en) Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders